Tian Wang is a Professor in the Department of Microbiology & Immunology, The University of Texas Medical Branch, USA. She received her PhD degree in Immunology at the University of Texas Medical Branch in 2000. She then completed postdoctoral
training in the area of vector-borne infectious pathogens at Yale University in 2004. She was an Assistant Professor at the Department of Microbiology, Immunology, and Pathology at Colorado State University during 2005–2008. She joined the University of Texas Medical Branch as an Assistant Professor in 2008 and was promoted to Professor in 2015. Since 2007,
she has served for NIH study sections in the areas of Immune Mechanisms of
Virus infection and Biodefense research. Her research focuses on understanding
the disease mechanisms of emerging and re-emerging RNA viruses, such as West
Nile virus, Zika virus, Powassan virus, Chikungunya virus, and SARS-CoV-2, host
immune responses to viruses and candidate vaccines, vaccine development, and
antiviral agents.
Research Keywords & Expertise
Immunity
Pathogenesis
Vaccines
flavivirus
West Nile encephalitis
Anti-viral agents
Short Biography
Tian Wang is a Professor in the Department of Microbiology & Immunology, The University of Texas Medical Branch, USA. She received her PhD degree in Immunology at the University of Texas Medical Branch in 2000. She then completed postdoctoral
training in the area of vector-borne infectious pathogens at Yale University in 2004. She was an Assistant Professor at the Department of Microbiology, Immunology, and Pathology at Colorado State University during 2005–2008. She joined the University of Texas Medical Branch as an Assistant Professor in 2008 and was promoted to Professor in 2015. Since 2007,
she has served for NIH study sections in the areas of Immune Mechanisms of
Virus infection and Biodefense research. Her research focuses on understanding
the disease mechanisms of emerging and re-emerging RNA viruses, such as West
Nile virus, Zika virus, Powassan virus, Chikungunya virus, and SARS-CoV-2, host
immune responses to viruses and candidate vaccines, vaccine development, and
antiviral agents.